Polpharma Biologics is a fully integrated biopharmaceutical CDMO offering the complete spectrum of services from discovery to drug substance and drug product development and manufacturing.
At Polpharma Biologics our extensive capabilities allow us to support your product for its entire life cycle. This means you don’t have to swap providers losing precious time and product expertise. We endeavor to do everything we can to get your product to the clinic.
Discovery to IND Capabilities:
Discovery & Optimization
We offer an extensive antibody discovery platform (CASH™) for novel therapeutics and antibody humanization utilizing best in class technology with extensive supporting bioassays.
Cell Line Development
We can develop high quality, high titer manufacturing cell lines utilizing our own proprietary CHO-K1 derived cell line, CHOBC™. Utilizing our SPOT™ and SLIM™ technology we can reach titers upwards of 9 g/l.
We utilize our extensive knowledge in our process modulation toolbox to quickly establish processes that will yield the optimal outcome at the highest level of efficiency. We apply quality-by-design (QbD) principles to guarantee the quality, safety and efficacy of your products.
Our state-of-the-art manufacturing facilities utilize the latest single use technology to produce drug substance and drug product for pre-clinical, clinical and commercial supply.
From Idea to Global Supply
We have extensive experience of taking new therapeutics through development and can support you on individual projects or use our experience not only in development but also in regulatory, quality and IP to accelerate your product to the clinic. We want to get your product to patients as quickly and safely as possible.